Published: August 6th 2024 | Updated: August 20th 2024
In This Issue: Total Pharmacy August 2024
Published: July 8th 2024 | Updated: July 10th 2024
SGLT2i, GLP-1RA Combination Therapy Offers Robust Protection Against Cardiovascular, Kidney Disease
Published: October 1st 2024 | Updated: October 3rd 2024
GLP-1s May Protect Against Cardiovascular Outcomes Regardless of Diabetes Status
Published: September 23rd 2024 | Updated: October 3rd 2024
PBM Issues Obscure a Bigger Challenge
Published: September 24th 2024 | Updated: October 3rd 2024
PCMA on Drug Pricing, Transparency, and the Role of PBMs
Published: September 26th 2024 | Updated: October 3rd 2024
Novo Nordisk CEO Agrees to Work With PBMs to Negotiate Lower Semaglutide List Prices